Patent · US Expired

Immunostimulatory nucleic acids

US7271156B2 · kind B2 · utility

86Cited by
20References
33Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 9, 2002
Grant dateSep 18, 2007
Priority date
Expiry dateDec 9, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55561
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to immunostimulatory nucleic acid compositions and methods of using the compositions. The T-rich nucleic acids contain poly T sequences and/or have greater than 25% T nucleotide residues. The TG nucleic acids have TG dinucleotides. The C-rich nucleic acids have at least one poly-C region and/ore greater than 50% c nucleotides. These immunostimulatory nucleic acids function in a similar manner to nucleic acids containing CpG motifs. The invention also encompasses preferred CpG nucleic acids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.